Natural Bioactive Compounds: Technological Advancements deals with the latest breakthroughs in the field of screening, characterization and novel applications of natural bioactive compounds from diverse group of organisms ranging from bacteria, viruses, cyanobacteria, algae, fungi, bryophytes, higher plants, sponges, corals and fishes. Written by some of the most reputed scientists in the field, this book introduces the reader to strategies and methods in the search for bioactive natural products. It is an essential read for researchers and students interested in bioactive natural products, their biological and pharmacological properties, their possible use as chemopreventive or chemotherapeutic agents, and other future potential applications. - Explores natural sources of bioactive compounds, including cyanobacteria, bacteria, viruses, fungi and higher plants - Discusses the potential applications of biological products, such as their use in medicine (antibiotics, cancer research, immunology), as food additives, supplements and technological substances - Analyzes the contributions of emerging or developing technologies for the study of bioactive natural compounds (characterization and purification)

Mosses, liverworts, and hornworts produce a large variety of compounds which exhibit remarkable biological activity. This book provides the first comprehensive survey of the chemistry, biology, and pharmacology of these extraordinary plant groups. Internationally recognized experts give readers valuable information on all aspects of the chemistry of bryophytes, including biochemical, botanical, pharmaceutical, chemotaxonomical, and environmental studies. In addition, synthetic studies of new natural products found in bryophytes are covered.

This reference work provides a comprehensive overview of bioactive compounds investigated in bryophytes and pteridophytes and explores their nutritional, biological, pharmacological and ecological effects. Bryophytes are cosmopolitan lower plants that are rich in phytochemicals including fatty acids, tocopherols, phenolics, terpenoids. Additionally, these plants contain bibenzyls, bis-benzyls, and polyketides which have been demonstrated to have antimicrobial, anti-inflammatory, and cytotoxic activities. Pteridophytes are another group of lower vascular plants which were reported to have useful secondary compounds such as flavonoids, steroids, phenolics, terpenoids, and these plants impart medicinal values including antioxidant, antimicrobial, anti-inflammatory, anti-tumor, and anti-HIV activities. This book contains comprehensive contributions compiled by expert scientists and researchers in this field.The book offers a useful resource for plant biotechnologists, plant biologists, pharmacologists, pharmacists, food technologists, nutritionists, research investigators of the healthcare industry, academia, faculty, and students of biology and biomedical sciences. It also provides a strategic framework for further research and development activities of bryophytes and pteridophytes of the world.

Bioactive Natural Products covers all the aspects of bioactive natural product research from ethnobotanical investigations to modern, technologically assisted isolation and structural determination of active compounds. An internationally selected group of experts share their knowledge of a wide range of bioactivities and chemical compound classes. Topics in the chapters describing the modern application of detection, isolation, and structural determination techniques are strongly supported by chapters detailing and reviewing research involving various classes of bioactivity. Research areas include the immunomodulatory, antiviral, cytotoxic, anti-inflammatory, and insect behavior classes of bioactivity. Extensive referencing throughout the text is helpful to those readers not familiar with this subject and serves as a critical review for more experienced researchers. The book is also excellent for upper division or post-graduate courses.

Proceedings of the 38th Annual Meeting at the Phytochemical Society of North America on Phytochemicals in Human Health Protection, Nutrition and Plant Defense, held July 26-31, 1998 in Pullman, WA, USA

Evolutionary Diversity as a Source for Anticancer Molecules discusses evolutionary diversity as source for anticancer agents derived from bacteria, algae, bryophytes, pteridophytes, and gymnosperms. The book goes over the isolation of anticancer agents and the technologyenabled screening process used to develop anticancer drugs. The book also includes discussion of the nutraceuticals and natural productsderived from invertebrates that can be used as part of cancer treatment. Evolutionary Diversity as a Source for Anticancer Molecules also deals with some of the current challenges in the prevention of cancer as well as the side effects of conventional drugs used for cancer patients.This book is a valuable resource for cancer researchers, oncologists, biotechnologists, pharmacologists, and any member of the biomedicalfield interested in understanding more about natural products with anticancer potential. - Discusses the application of natural products in place of conventional drugs to minimize the side effects in cancer treatment - Explains the relation between evolutionary mechanisms and climate change for production of secondary metabolites

Published in 1990: With the accumulation of knowledge in the newer areas of investigations and the increasing degree of specialization, the most satisfactory way of bringing together authentic information in one volume is to invite the specialists in each area to contribute.